4//SEC Filing
Wellinghoff Darryl 4
Accession 0000920465-20-000015
CIK 0000920465other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:18 PM ET
Size
5.4 KB
Accession
0000920465-20-000015
Insider Transaction Report
Form 4
Wellinghoff Darryl
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-01-09+30,000→ 30,000 totalExercise: $5.25Exp: 2030-01-09→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years.
Documents
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001770350
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 4:18 PM ET
- Size
- 5.4 KB